Skip to main content

Company News

  • May 19, 2025

    bioMérieux Partners with First U.S. Hospital to Use VITEK® REVEAL™ Fast AST for Blood Stream Infections 

    bioMérieux is partnering with AdventHealth Orlando as they become the first institution to adopt the VITEK® REVEAL™ Fast Antimicrobial Susceptibility Testing (AST) System for clinical use in the United States.

  • April 17, 2025

    bioMérieux Embarks its Customers in a Circular Economy Initiative

    BIOLOOP™ est un projet innovant visant à recycler les boîtes de Petri en plastique provenant de déchets infectieux pour en faire de nouveaux emballages de réactifs - réduisant ainsi les émissions de CO₂ et soutenant une économie circulaire dans le domaine des soins de santé.
  • February 24, 2025

    bioMérieux and Vall d'Hebron Join Forces Against Infectious Diseases

    bioMérieux announces a new strategic research partnership with Vall d'Hebron, one of Spain's largest and most prestigious healthcare institutions. This collaboration aims to advance research and development in the areas of infectious diseases, data surveillance, and laboratory automation.
  • January 07, 2025

    bioMérieux, Tampa General Hospital and USF Health Host AMR Summit to Drive Action on Antimicrobial Resistance

    bioMérieux, Tampa General Hospital (TGH) and USF Health hosted the inaugural U.S. AMR Summit Nov. 12-13 to address the escalating global threat of antimicrobial resistance (AMR).

  • November 28, 2024

    With E-Resale, bioMérieux innovates by giving a second life to its instruments

    Launched last July, starting with Africa and Middle East, the E-Resale platform allows to purchase and sell second-hand bioMérieux instruments for clinical applications. This is an innovative offer in the field of circular economy and a first on the in vitro diagnostics market.

Follow us on Socials for more news!